Logo image of THW

ABRDN WORLD HEALTHCARE FUND (THW) Stock Price, Quote, News and Overview

NYSE:THW - New York Stock Exchange, Inc. - US87911L1089 - Currency: USD

11.07  +0.02 (+0.18%)

Fundamental Rating

2

Overall THW gets a fundamental rating of 2 out of 10. We evaluated THW against 0 industry peers in the Unkown industry. Both the profitability and financial health of THW have multiple concerns. THW does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year THW was profitable.
THW had positive earnings in 4 of the past 5 years.
Of the past 5 years THW 4 years had a positive operating cash flow.
THW Yearly Net Income VS EBIT VS OCF VS FCFTHW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA 0.35%
ROE 0.45%
ROIC N/A
ROA(3y)3.66%
ROA(5y)6.8%
ROE(3y)4.51%
ROE(5y)8.57%
ROIC(3y)N/A
ROIC(5y)N/A
THW Yearly ROA, ROE, ROICTHW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

In the last couple of years the Profit Margin of THW has remained more or less at the same level.
The Operating Margin and Gross Margin are not available for THW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 15.96%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-1.16%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
THW Yearly Profit, Operating, Gross MarginsTHW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

3

2. Health

2.1 Basic Checks

THW has less shares outstanding than it did 1 year ago.
The number of shares outstanding for THW has been increased compared to 5 years ago.
THW has a better debt/assets ratio than last year.
THW Yearly Shares OutstandingTHW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
THW Yearly Total Debt VS Total AssetsTHW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

THW has an Altman-Z score of 2.06. This is not the best score and indicates that THW is in the grey zone with still only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.27 indicates that THW is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 2.06
ROIC/WACCN/A
WACCN/A
THW Yearly LT Debt VS Equity VS FCFTHW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 1.72 indicates that THW should not have too much problems paying its short term obligations.
THW has a Quick Ratio of 1.72. This is a normal value and indicates that THW is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.72
THW Yearly Current Assets VS Current LiabilitesTHW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

THW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -92.97%.
The Earnings Per Share has been growing slightly by 2.00% on average over the past years.
The Revenue has decreased by -0.42% in the past year.
The Revenue has been growing slightly by 0.88% on average over the past years.
EPS 1Y (TTM)-92.97%
EPS 3Y2%
EPS 5YN/A
EPS Q2Q%-157.05%
Revenue 1Y (TTM)-0.42%
Revenue growth 3Y4.2%
Revenue growth 5Y0.88%
Sales Q2Q%-2.11%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
THW Yearly Revenue VS EstimatesTHW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 123.00, which means the current valuation is very expensive for THW.
THW is valuated expensively when we compare the Price/Earnings ratio to 26.93, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 123
Fwd PE N/A
THW Price Earnings VS Forward Price EarningsTHW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
THW Per share dataTHW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

THW has a Yearly Dividend Yield of 11.89%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.39, THW pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.89%

5.2 History

The dividend of THW decreases each year by -1.22%.
THW has been paying a dividend for at least 10 years, so it has a reliable track record.
THW has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-1.22%
Div Incr Years0
Div Non Decr Years9
THW Yearly Dividends per shareTHW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
THW Yearly Income VS Free CF VS DividendTHW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

More info and screens

ABRDN WORLD HEALTHCARE FUND

NYSE:THW (8/14/2025, 5:05:00 PM)

11.07

+0.02 (+0.18%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners13.48%
Inst Owner Change4.13%
Ins Owners0.01%
Ins Owner Change0%
Market Cap441.14M
Analysts0
Price TargetN/A
Short Float %0.29%
Short Ratio0.61
Dividend
Industry RankSector Rank
Dividend Yield 11.89%
Yearly Dividend1.31
Dividend Growth(5Y)-1.22%
DPN/A
Div Incr Years0
Div Non Decr Years9
Ex-Date07-24 2025-07-24 (0.1167)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 123
Fwd PE N/A
P/S 35.21
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)0.09
EY0.81%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.31
BVpS11.19
TBVpS11.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 0.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 15.96%
GM N/A
FCFM N/A
ROA(3y)3.66%
ROA(5y)6.8%
ROE(3y)4.51%
ROE(5y)8.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-1.16%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.72
Quick Ratio 1.72
Altman-Z 2.06
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.97%
EPS 3Y2%
EPS 5YN/A
EPS Q2Q%-157.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.42%
Revenue growth 3Y4.2%
Revenue growth 5Y0.88%
Sales Q2Q%-2.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11.5%
FCF growth 3YN/A
FCF growth 5Y19.73%
OCF growth 1Y11.5%
OCF growth 3YN/A
OCF growth 5Y19.73%